Disease Detail

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Molecular Profile Therapy Indication/Tumor Type Response Type Profile Response Detail
FGFR1 amp AZD4547 lung large cell carcinoma sensitive detail...
FGFR1 positive AZD4547 + AZD8055 lung large cell carcinoma sensitive detail...
FGFR1 positive AZD4547 + Vistusertib lung large cell carcinoma sensitive detail...
FGFR1 positive AZD4547 + Sirolimus lung large cell carcinoma sensitive detail...
MET del exon14 TP53 N30fs Capmatinib lung large cell carcinoma sensitive detail...
TP53 R175L NSC319726 lung large cell carcinoma sensitive detail...
TP53 wild-type NSC319726 lung large cell carcinoma resistant detail...
FGFR1 amp ODM-203 lung large cell carcinoma sensitive detail...
Clinical Trial Phase Therapies Title Recruitment Status
NCT02185690 Phase I MEK162 + Carboplatin + Pemetrexed A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung Recruiting